STAT3 and cancer: Developing a STAT3 inhibitor that simultaneously inhibitsSTAT3 Tyr705 and Ser727 phosphorylation would achieve an adequateinhibition of STAT3, and may achieve a highly potent therapeutic benefitfor cancer treatment.